This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for weight loss and weight management in people with ...

The UK is one of the heaviest nations in Europe now with 64 per cent of the population overweight or obese, and one in four of those people are classed as obese.

Imagine this scenario: You’ve been diligently working toward your weight management goals, and your healthcare team has prescribed Wegovy (semaglutide). You’re excited, you’ve done your research, and ...

Losing weight with the help of a prescription weight loss drug continues to increase in popularity. According to recent K FF polls, about one in eight U.S. adults takes a GLP-1 medication for weight ...

The arrival of the Wegovy pill (semaglutide), the first oral GLP-1 drug approved to treat obesity, means freedom of choice: Adults who are looking to lose weight and have at least one weight-related ...